Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery

18 May 2023

Abstract excerpt

The lack of potent antiviral drugs for SARS-CoV-2 is a serious global health concern, especially with the explosive spread of the COVID-19 pandemic worldwide and the constant emergence of new mutant strains with improved human-to-human transmission. Although an effective coronavirus vaccine appears promising, the lengthy vaccine development processes in general and the emergence of new mutant viral strains with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to interferon and immune responses
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37199631
DOI: 10.1128/spectrum.01186-23

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug DiscoveryPMID 37199631Read ↗

Insights into SARS-CoV-2 evolution, potential antivirals, and vaccinesSemantic proximity Read ↗

TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)Semantic proximity Read ↗

Structural biology of SARS-CoV-2: open the door for novel therapiesSemantic proximity Read ↗

Novel Antiviral Therapeutic Against SARS-CoV-2 and its Variants: Recent Developments and Future PerspectivesSemantic proximity Read ↗

Recent advances in small-molecular therapeutics for COVID-19Semantic proximity Read ↗

Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronavirusesSemantic proximity Read ↗

Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeuticsSemantic proximity Read ↗

Nucleocapsid as a next-generation COVID-19 vaccine candidateSemantic proximity Read ↗

Druggable targets and therapeutic development for COVID-19Semantic proximity Read ↗

A comprehensive review on the global efforts on vaccines and repurposed drugs for combating COVID-19Semantic proximity Read ↗

Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniquesSemantic proximity Read ↗

An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment StrategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.